tradingkey.logo

Kenvue rises after $48.7 billion buyout deal from Kimberly-Clark

ReutersNov 3, 2025 11:52 AM

Shares of consumer health company Kenvue KVUE.N rise 20.2% to $17.27 premarket

Kimberly-Clark KMB.O says it will acquire the Tylenol maker in a deal valued at about $48.7 billion

Separately, co reports Q3 adj. EPS of 28 cents vs Wall Street estimates of 27 cents - LSEG data

Up to last close, stock was down ~33% YTD

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI